Filter Results:
(74)
Show Results For
- All HBS Web
(119)
- News (25)
- Research (74)
- Events (1)
- Multimedia (2)
- Faculty Publications (43)
Show Results For
- All HBS Web
(119)
- News (25)
- Research (74)
- Events (1)
- Multimedia (2)
- Faculty Publications (43)
←
Page 4 of 74
Results
Sort by
- 30 May 2007
- Research & Ideas
Health Care Under a Research Microscope
system had been brought to the table. That's all changing now, and the major players seem increasingly receptive to rethinking the system. He points to the Medicare Drug Prescription Plan, launched in 2006,... View Details
- 19 Sep 2017
- First Look
First Look at New Research and Ideas, September 19
https://www.hbs.edu/faculty/Pages/item.aspx?num=53199 forthcoming Industrial and Corporate Change Toward a Prescriptive Theory of Dynamic Capabilities: Connecting Strategic Choice, Learning, and Competition By: Pisano, Gary P. Abstract—The... View Details
Keywords: Sean Silverthorne
- 09 Aug 2016
- First Look
August 9, 2016
spending in the United States, accounting for less than 1% of prescriptions filled but nearly 28% of drug spending. Whereas traditional (chemically synthesized, "small-molecule") View Details
Keywords: Sean Silverthorne
- 12 Jul 2020
- Research & Ideas
Solving COVID'S Mental Health Crisis
community-based organizations. COVID-19 has disrupted GPP’s school-based activities, which include teacher training and the Teen Advisory Council, a program that supports students as they educate their peers about the dangers of View Details
- 17 Sep 2001
- Research & Ideas
Why E-commerce Didn’t Die With the Fall of Webvan
drugs for chronic conditions—from pharmacies to a combination of direct mail and telephone. The idea was that if you have a chronic condition, you're in a replenishment mode. You have to fill the View Details
- 08 Apr 2009
- Research & Ideas
Clayton Christensen on Disrupting Health Care
screening participants in drug trials and make it possible to track and troubleshoot unexpected problems that show up after a drug is introduced into the general population, like what happened with Vioxx.... View Details
- 01 Aug 2017
- First Look
First Look at New Research and Ideas, August 1
Scott Morton, Fiona, Ariel Dora Stern, and Scott Stern Abstract—Biologic drugs (therapeutic proteins or “large-molecule drugs”) represent a substantial and growing share of the U.S. drug market, accounting... View Details
Keywords: Sean Silverthorne
- 27 Sep 2011
- First Look
First Look: September 27
Even in the absence of national health coverage, the United States became the world's largest prescription drug market and emerged as the global leader in new drug research and... View Details
Keywords: Sean Silverthorne
- 12 Jul 2006
- Research & Ideas
Competition the Cure for Healthcare
the various actors in the system are not designed around value, nor is competition reinforcing improvements in value. For example, let's take the prescription drug benefit, the big reform of today that... View Details
- 13 Sep 2011
- First Look
First Look: September 13
adequate because they possess the Invariant Proportion of Substitution (IPS) property, which imposes counter-intuitive restrictions on individual choice behavior. Indeed our empirical application to prescription writing choices of... View Details
Keywords: Sean Silverthorne
- 07 Aug 2007
- First Look
First Look: August 7, 2007
and issues around current practices. Purchase this note: http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=807124 U.S. Food and Drug Administration Harvard Business School Note 807-050 Describes the U.S. FDA with particular... View Details
Keywords: Martha Lagace
- 30 Jun 2020
- Book
Capitalism Is More at Risk Than Ever
The book Capitalism at Risk first appeared in 2011. The problems it identified with social inequality, global trade strife, and environmental degradation have only accelerated by 2020. The new edition of Capitalism at Risk, subtitled How Business Can Lead, is expanded... View Details
Keywords: by Martha Lagace
- 13 Jan 2009
- First Look
First Look: January 13, 2009
and regulation of clinical trials, managerial challenges related to pharmaceutical product testing, and current debates regarding prescription drug safety. Since clinical testing takes between five and seven... View Details
Keywords: Martha Lagace